Almirall and Forest Laboratories to expand respiratory collaboration with LAS100977

The agreement refers to OD LABA LAS100977, Almirall’s once daily long-acting beta-agonist, for the treatment of asthma and COPD using the Genuair ® device

The release as fetched from its publisher. almirall.com ↗